Howdy pricing people! After a short break for paternity leave (we welcomed a baby boy!) we're back with a new Office Hours session. This is going to be a good one -- I'll be joined by @Arnon Shimoni (Solvimon) and @Ulrik Lehrskov-Schmidt (Willingness to Pay) on something I get asked about constantly: how to iterate on pricing faster. What's fun about this pairing is they cover both sides: - Ulrik takes the strategy side — how to read willingness to pay and decide what to change. - Arnon takes the execution side — how to actually ship pricing and billing changes in minutes instead of getting stuck for months. A few things we're going to dig into: - How do you move fast on pricing without breaking things downstream? - The build-vs-buy trap — why teams try to roll their own billing and underestimate what they're signing up for. - How the fastest-moving companies are pricing AI products right now. This is Q&A-first, so bring your questions — we'll work through as many as we can live. Details below: Wednesday, August 12th @ 11am EST Register here 👉 https://luma.com/8f0n6xrx Hope to see you there! Rob

Working with a customer to implement RevTurbine (revturbine.com). We are implementing a reverse trial which is triggered by the key onboarding action (connecting the user's trading account), and used as an incentive to complete it. The trial is on a separate hidden tier (subset of lowest paid plan features) which provides great flexibility: play with limits to control AI costs, segment however you like (e.g. higher limits for stronger prospects), etc - which is all in line with the customer promise: 21 day trial (no tier specified). And you have usage/feature based upsells to the paid tier during the trial (on top of the time limit as a conversion moment). This feels like it could be applicable to other folks, so thought would share. Happy to hear any comments/questions also.

According to Google, the majority of SaaS companies today selling contracts worth over $100K use a version of MEDDPICC as their sales method. I'd like to ask this community whether they use MEDDPICC at their company. If so, what influence does that have on your pricing?

80% of responses said they’ve added AI features and either haven’t changed pricing or customers haven’t cared. https://forstarters.substack.com/p/for-starters-83-the-monetization This suggests to me the NRR squeeze is less about absorbing variable token costs, and more about a misalignment between product and commercialization.

Pricing used to last 18 months. Now it's down to 6.: https://www.growthunhinged.com/p/saas-pricing-out-of-date?utm_source=newsletter.failory.com&utm_medium=newsletter&utm_campaign=another-agent-down&_bhlid=4427d97d533f207184fc14b086a83d01cc77319b